Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Safety and Feasibility Study of Chimeric Antigen Receptor (CAR) T Cell Therapy with YESCARTA in the Outpatient Setting

Lymphoma

Lymphoma
N/A
Oluwole, Olalekan
NCT05108805
VICCCTT2109

To learn more about any of our clinical
trials, call 615-936-8422.